True Health Files for HKEX Listing, Core Percutaneous Puncture Surgical Robot Obtains NMPA Registration

NewTimeSpace News: As disclosed by HKEX, Guangdong True Health Medical Technology Development Co., Ltd. filed its Main Board listing application with the Hong Kong Stock Exchange on June 8, 2026, with CICC and DBS Group serving as joint sponsors.
Established in 2018, True Health dedicates itself to the research, development and commercialization of percutaneous puncture and ablation surgical robots. Its core product, the percutaneous puncture surgical robot, comes in four models including TH-S1, TH-S, TH-S Pro and TH-SA. All of them have been granted Class III registration certificates by the National Medical Products Administration, and are approved for pulmonary and abdominal puncture procedures. In addition, the company has two key approved products, namely the percutaneous microwave ablation surgical robots TH-X MW and TH-X HMW, as well as a number of other product candidates.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.